Despina Mallouri

Limassol General Hospital — CY

Medicine · Health Sciences

14h-index660citations82works3.62yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(31), Acute Myeloid Leukemia Research(15), Acute Lymphoblastic Leukemia research(14), Renal Transplantation Outcomes and Treatments(13), Complement system in diseases(13)

Publications82 total

Treosulfan-Based Conditioning Regimens for Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia and Other Myeloid Malignancies
Pharmaceuticals·2025Open Access
Safety and long-term efficacy of autologous hematopoietic cell transplantation for patients with systemic sclerosis
Frontiers in Medicine·2025· 2 citedOpen Access
Management strategies for CAR-T cell therapy-related toxicities: results from a survey in Greece
Frontiers in Medicine·2025· 3 citedOpen Access
Evaluation of Cognitive Impairment and Neurotoxicity Post CAR-T Cell Therapy.
Transplantation and Cellular Therapy·2025
Long-Term Safety and Efficacy of Treosulfan-Based Conditioning Regimens of Allogeneic Hematopoietic Cell Transplantation
Blood·2024· 1 cited
Long-Term Safety and Efficacy of Autologous Hematopoietic Cell Transplantation for Patients with Progressive Systemic Sclerosis
Blood·2024· 1 citedOpen Access
Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) and Growth Differentiation Factor-15 (GDF-15) Levels Are Significantly Associated with Endothelial Injury Indices in CAR-T Cell Recipients
Blood·2024
Nationwide Multicenter Real-World Survey of CAR-T Cell Toxicity Prophylactic and Treatment Management Strategies
Blood·2024· 2 citedOpen Access
Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR), Growth Differentiation Factor-15 (GDF-15), and Soluble C5b-9 (sC5b-9) Levels Are Significantly Associated with Endothelial Injury Indices in CAR-T Cell Recipients
International Journal of Molecular Sciences·2024· 6 citedOpen Access
Safety and Efficacy of Extracorporeal Photopheresis for Acute and Chronic Graft-versus-Host Disease
Pharmaceuticals·2024· 7 citedOpen Access
EASIX and m-EASIX predict severe cytokine release syndrome and overall survival after CAR T-cell therapy
Blood Vessels Thrombosis & Hemostasis·2024· 10 citedOpen Access
Alteration of Gut Microbiota Composition and Diversity in Acute and/or Chronic Graft-versus-Host Disease Following Hematopoietic Stem Cell Transplantation: A Prospective Cohort Study
International Journal of Molecular Sciences·2024· 8 citedOpen Access
Open-Label Randomized Controlled Study of Ciprofloxacin vs Rifaximin as Neutropenia Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation
Transplantation Proceedings·2024· 7 citedOpen Access
Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) and Growth Differentiation Factor-15 (GDF-15) Levels Are Significantly Associated with Endothelial Injury Indices in Adult Allogeneic Hematopoietic Cell Transplantation Recipients
International Journal of Molecular Sciences·2023· 6 citedOpen Access
Pre-Emptive Use of Rituximab in Epstein–Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and Outcomes
International Journal of Molecular Sciences·2023· 6 citedOpen Access
Easix Indices Predict CRS and Overall Survival in Adult CAR-T Cell Recipients
Blood·2023· 9 cited
Safety and Efficacy of Extracorporeal Photopheresis for Acute and Chronic Graft-Versus-Host-Disease
Blood·2023Open Access
Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) and Growth Differentiation Factor-15 (GDF-15) Leves Are Significantly Associated with Edothelial Injury Indices in Adult Allogenic Hematopoietic Cell Transplantation Recipients
Blood·2023Open Access
P1311: LONG-TERM SAFETY AND EFFICACY OF EXTRACORPOREAL PHOTOPHERESIS AS EARLY SECOND-LINE TREATMENT FOR PATIENTS WITH STEROID-DEPENDENT OR REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE.
HemaSphere·2023Open Access
PB2261: DECREASE IN NEUTROPHIL-LYMPHOCYTE RATIO IMPACTS OVERALL SURVIVAL OF ADULT PATIENTS WITH HODGKIN LYMPHOMA AFTER ANTI-PD1 TREATMENT
HemaSphere·2023Open Access
page 1 of 5Next →

Frequent Co-authors

Ioannis Batsis(48), Ioanna Sakellari(47), Eleni Gavriilaki(42), Αchilles Anagnostopoulos(38), Evangelia Yannaki(30), Anna Vardi(28), Zoi Bousiou(26), Apostolia Papalexandri(20), Damianos Sotiropoulos(20), Varnavas Constantinou(14), Tasoula Touloumenidou(12), Panayotis Kaloyannidis(11), Marianna Masmanidou(10), Anastasia Athanasiadou(9), Chrysavgi Lalayanni(8), Christos Demosthenous(8), Alkistis Panteliadou(8), Nikolaos Spyridis(8), Christos Smias(7), Anastasia Marvaki(7)